Global Microneedle Flu Vaccine Market- Regional Analysis
Among region, North America is expected to dominate the market over the forecast period. This is attributed to the increasing adoption of organic growth strategies such as expansion by key players in the region to expand their product portfolio which is expected to drive the market growth over the forecast period. For instance, in October 2021, Vaxess Technologies Inc., engaged in developing biomedical innovations with a focus on improving access to vaccines, announced the grand opening of a Good Manufacturing Practice (GMP) manufacturing facility, a GMP Facility is a production facility or a clinical trial materials pilot plant for the manufacture of pharmaceutical products. Vaxess Technologies Inc. is focused on developing a pipeline of MIMIX therapies.
The Europe region is expected to be the second largest region over the forecast period, owing to increasing research and development activities by key players in the region to expand product portfolio, which is expected to drive the market growth over the forecast period. For instance, in October 2021, LTS Lohmann Therapie-Systeme AG, a developer and manufacturer of transdermal systems and oral thin films, announced that it has expanded the research and development area for microneedles.
Microneedle Flu Vaccine Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients